Saharkhiz Nasrin, Salehpoor Saghar, Hosseini Sedigheh, Nazari Leila, Sheibani Samaneh, Doohandeh Tahereh
Preventive Gynecology Research Center, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Preventive Gynecology Research Center, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Email:
Int J Fertil Steril. 2024 Feb 2;18(2):135-139. doi: 10.22074/ijfs.2023.552687.1293.
Various protocols have been approved to improve the response rate leading to successful fertilization in poor ovarian responders (PORs). The application of double ovarian stimulation (DuoStim) in the follicular and luteal phases of the same ovarian cycle has been shown as an intriguing option to achieve more oocyte retrievals in the shortest time. The aim of the current study is to compare the outcomes of different protocols, minimal stimulation (MS) and Duostim.
This randomized clinical trial was performed on 42 fertilization (IVF) candidates with POR diagnosis. Patients were classified into two equal groups and treated with the DuoStim protocol and MS protocol. The IVF outcomes, including retrieved follicles, oocytes, metaphase II (MII) oocytes and embryos, were compared between these groups.
The patients' characteristics including age, anti-mullerian hormone (AMH), follicle stimulating hormone (FSH), luteinizing hormone (LH), and antral follicle count (AFC) were collected and compared. It showed there was no significant difference between the two groups baseline characteristics (P>0.05). We observed that the DuoStim protocol resulted in a significantly higher score in comparison with the MS protocols , including the number of follicles (6.23 ± 2.93 vs. 1.77 ± 1.66, P<0.001), retrieved oocytes (3.86 ± 2.57 vs. 1.68 ± 1.58, P=0.002), MII oocytes (3.36 ± 2.42 vs. 1.27 ± 1.27, P=0.001) and obtained embryos (2.04 ± 1.64 vs. 0.77 ± 0.86, P=0.003).
The DuoStim protocol is a favourable and time saving plan that is associated with more oocytes in a single stimulation cycle. The DuoStim protocol significantly can result in more frequent MII oocytes and embryos. We figured that the higher number of oocytes and embryos might have led to a higher rate of pregnancy (registration number: IRCT20200804048303N1).
已经批准了各种方案来提高反应率,从而使卵巢反应不良者(POR)成功受精。在同一卵巢周期的卵泡期和黄体期应用双重卵巢刺激(DuoStim)已被证明是一种在最短时间内获得更多卵母细胞的有趣选择。本研究的目的是比较不同方案——最小刺激(MS)和DuoStim——的结果。
本随机临床试验对42名诊断为POR的体外受精(IVF)候选者进行。患者被分为两组,分别采用DuoStim方案和MS方案进行治疗。比较两组的IVF结果,包括回收的卵泡、卵母细胞、中期II(MII)卵母细胞和胚胎。
收集并比较了患者的年龄、抗苗勒管激素(AMH)、卵泡刺激素(FSH)、黄体生成素(LH)和窦卵泡计数(AFC)等特征。结果显示两组基线特征无显著差异(P>0.05)。我们观察到,与MS方案相比,DuoStim方案的得分显著更高,包括卵泡数量(6.23±2.93对1.77±1.66,P<0.001)、回收的卵母细胞(3.86±2.57对1.68±1.58,P=0.002)、MII卵母细胞(3.36±2.42对1.27±1.27,P=0.001)和获得的胚胎(2.04±1.64对0.77±0.86,P=0.003)。
DuoStim方案是一种有利且节省时间的方案,在单个刺激周期中可获得更多卵母细胞。DuoStim方案可显著产生更频繁的MII卵母细胞和胚胎。我们认为,更多的卵母细胞和胚胎数量可能导致更高的妊娠率(注册号:IRCT20200804048303N1)。